<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04420832</url>
  </required_header>
  <id_info>
    <org_study_id>ATR ultrasound study</org_study_id>
    <nct_id>NCT04420832</nct_id>
  </id_info>
  <brief_title>Acute Achilles Tendon Rupture - Choice of Treatment Based on Ultrasound Findings</brief_title>
  <acronym>DUSTAR</acronym>
  <official_title>Diagnostic UltraSonography for the Choice of Treatment of Acute Achilles Tendon Rupture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with acute achilles tendon rupture will go through an acute ultrasound. Based on the
      distance between the ends of the tendon the investigators will decide if the patient is going
      to be treated with or without surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in functional outcome between patients treated surgically and non-surgically</measure>
    <time_frame>3 months</time_frame>
    <description>The primary outcome will be a comparison of function by the heel-rise work test developed by Silbernagel et al. This is a validated test which combines both the height of each heel-rise and the number of repetitions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in functional outcome between patients treated surgically and non-surgically</measure>
    <time_frame>6 months</time_frame>
    <description>The primary outcome will be a comparison of function by the heel-rise work test developed by Silbernagel et al. This is a validated set of tests measuring vertical jump, strength and endurance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in functional outcome between patients treated surgically and non-surgically</measure>
    <time_frame>12 months</time_frame>
    <description>The primary outcome will be a comparison of function by the heel-rise work test developed by Silbernagel et al. This is a validated set of tests measuring vertical jump, strength and endurance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in functional outcome between patients treated surgically and non-surgically</measure>
    <time_frame>24 months</time_frame>
    <description>The primary outcome will be a comparison of function by the heel-rise work test developed by Silbernagel et al. This is a validated set of tests measuring vertical jump, strength and endurance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultrasonography (US)</measure>
    <time_frame>6 months</time_frame>
    <description>Achilles tendon length - measured using US extended field of view</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasonography (US)</measure>
    <time_frame>12 months</time_frame>
    <description>Achilles tendon length - measured using US extended field of view</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasonography (US)</measure>
    <time_frame>24 months</time_frame>
    <description>Achilles tendon length - measured using US extended field of view</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achilles Tendon Rupture Score (ATRS)</measure>
    <time_frame>3 months</time_frame>
    <description>Patient reported outcome measure (PROM) specific for achilles tendon rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achilles Tendon Rupture Score (ATRS)</measure>
    <time_frame>6 months</time_frame>
    <description>Patient reported outcome measure (PROM) specific for achilles tendon rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achilles Tendon Rupture Score (ATRS)</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported outcome measure (PROM) specific for achilles tendon rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achilles Tendon Rupture Score (ATRS)</measure>
    <time_frame>24 months</time_frame>
    <description>Patient reported outcome measure (PROM) specific for achilles tendon rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Scale (PAS)</measure>
    <time_frame>3 months</time_frame>
    <description>PROM to measure overall physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Scale (PAS)</measure>
    <time_frame>6 months</time_frame>
    <description>PROM to measure overall physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Scale (PAS)</measure>
    <time_frame>12 months</time_frame>
    <description>PROM to measure overall physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Scale (PAS)</measure>
    <time_frame>24 months</time_frame>
    <description>PROM to measure overall physical activity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Achilles Tendon Rupture</condition>
  <condition>Athletic Injuries</condition>
  <condition>Ultrasonography</condition>
  <condition>Rupture</condition>
  <condition>Acute Disease</condition>
  <arm_group>
    <arm_group_label>Surgical treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a distance of 5 mm or more between tendon ends will be treated surgically and with physiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-surgical treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with a distance of less than 5 mm between tendon ends will be treated non-surgically and with physiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical treatment</intervention_name>
    <description>Se above</description>
    <arm_group_label>Surgical treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-surgical treatment</intervention_name>
    <description>See above</description>
    <arm_group_label>Non-surgical treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute achilles tendon rupture diagnosed less than 48 hours from injury

          -  mid-substance rupture

        Exclusion Criteria:

          -  previous achilles tendon rupture

          -  lower leg disability

          -  diabetes mellitus

          -  neurovascular disease

          -  immunosuppression

          -  non-Swedish speaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Katarina Nilsson Helander</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Disease</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Athletic Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

